A Randomized, Double-Blind, Placebo-Controlled, Multicentered Study to Evaluate the Efficacy and Safety of MEI005 in Reducing Submental Fat in Chinese Adults.

Aesthetic surgery journal 2025 Vol.45(6) p. 629-637

Ting W, Wen J, Li Z, Sun J, Zhang J, Shu M, Liu H, He L, Yu B, Jiang N, Xue C, Tan Q, Xu X, Wu S, Jian D, Zhao H, Wang L, Yu N, Wang X

관련 도메인

Abstract

[BACKGROUND] Submental fat (SMF) is a common aesthetic concern traditionally treated with liposuction. Nonsurgical alternatives, like injectable deoxycholic acid, are gaining popularity. However, no related products have been clinically approved in China.

[OBJECTIVES] This study evaluated the efficacy and safety of MEI005, a deoxycholic acid-based injectable formulation, in reducing SMF in Chinese adults.

[METHODS] This multicenter, randomized, double-blind, placebo-controlled Phase III trial included 325 Chinese adults with moderate-to-severe SMF. Participants received MEI005 or a placebo injection every 28 days for up to 6 sessions. Primary endpoints were ≥2-grade improvements in Clinician and Patient-Reported Submental Fat Rating Scales (CR-SMFRS and PR-SMFRS). Secondary endpoints included SMF volume reductions measured by MRI; patient-reported outcomes on the Patient-Reported Submental Fat Impact Scale (PR-SMFIS) and Subject Self-Rating Scale (SSRS); and SMF thickness reductions measured by caliper. Adverse events (AEs), self-reports, clinical examinations, and checks for skin laxity were monitored.

[RESULTS] At 12 weeks posttreatment, 18.9% of MEI005 recipients demonstrated simultaneously ≥2-grade CR-SMFRS and PR-SMFRS improvement vs 1.8% for placebo (P < .001). Additionally, 68.9% of MEI005 group participants achieved simultaneously ≥1-grade improvement in CR-SMFRS and PR-SMFRS, compared with 21.6% of placebo (P < .001). MRI revealed ≥10% SMF volume reduction in 50% of MEI005 patients vs 15.2% of placebo (P < .001). Scores on the PR-SMFIS and SSRSs showed greater psychological improvement and satisfaction among MEI005 recipients. Vernier caliper measurements showed a 21.42% thickness reduction vs 6.32% (P < .001). AEs were mostly mild to moderate.

[CONCLUSIONS] MEI005 effectively reduces SMF, offering a safe, minimally invasive option for Chinese adults.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 liposuction 지방흡입 dict 1
해부 Fat scispacy 1
해부 skin scispacy 1
합병증 Fat scispacy 1
약물 SMF → Submental fat scispacy 1
약물 deoxycholic acid C0011479
deoxycholic acid
scispacy 1
약물 deoxycholic acid-based scispacy 1
약물 MEI005 scispacy 1
약물 [BACKGROUND] Submental scispacy 1
약물 [OBJECTIVES] scispacy 1
약물 deoxycholic scispacy 1
약물 PR-SMFIS → Patient-Reported Submental Fat Impact Scale scispacy 1
약물 [CONCLUSIONS] MEI005 scispacy 1
질환 SMF volume reductions scispacy 1
질환 SMF → Submental fat scispacy 1
질환 SSRS → Subject Self-Rating Scale scispacy 1
질환 AEs → Adverse events scispacy 1
질환 PR-SMFRS scispacy 1
기타 SMF → Submental fat scispacy 1
기타 recipients scispacy 1
기타 participants scispacy 1
기타 patients scispacy 1
기타 PR-SMFIS → Patient-Reported Submental Fat Impact Scale scispacy 1
기타 SSRSs scispacy 1

MeSH Terms

Humans; Double-Blind Method; Female; Adult; Male; Deoxycholic Acid; Middle Aged; Subcutaneous Fat; China; Treatment Outcome; Injections, Subcutaneous; Magnetic Resonance Imaging; Patient Reported Outcome Measures; Young Adult; Chin; Cosmetic Techniques; Patient Satisfaction; East Asian People

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문